Greenfern Industries Limited (GFI.NZ)

0.0340 0.0000 (0.00%) At close: 04:37PM NZST

Greenfern Industries Limited

General Capital House
Level 8 115 Queen Street
Auckland 1140
New Zealand
64 9 304 0145
https://gfi.nz

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Daniel Casey	MD & Exec. Director	176.2k	N/A	N/A
Mr. Hao Long	Chief Financial Officer	N/A	N/A	N/A
- Matthew	Operations Mang.	N/A	N/A	N/A
Mr. Jeremy Mills-Houlihan	Head of Cultivation	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.

Description

Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.

Corporate governance

Greenfern Industries Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.